첫 페이지 News 본문

On Monday, local time, Novo Nordisk, the manufacturer of the "slimming miracle drug", announced that it has agreed to purchase a hypertension control drug, Octurenone, from KBP Biosciences for up to $1.3 billion. This is a continuation of Novo Nordisk's recent series of transactions to strengthen its drug product line.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
您需要登录后才可以回帖 登录 | Sign Up

本版积分规则

chilunl 新手上路
  • Follow

    0

  • Following

    0

  • Articles

    0